IFNA1 and immunoglobulin G4-related sclerosing disease: Taken together, these data strongly suggest that serum concentrations of IFN-α and IL-33 can be useful biomarkers not only for the diagnosis of type 1 AIP/IgG4-RD, but also for the assessment of disease activity.